Dry powder formulation comprising a corticosteroid and a beta-adrenergic for administration by inhalation
US10946029B2 · kind B2 · utility
0Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 22, 2018 |
| Grant date | Mar 16, 2021 |
| Priority date | — |
| Expiry date | Jun 22, 2038 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P11/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compositions comprising a corticosteroid and a beta-adrenergic are useful for treating inflammatory or obstructive airways diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.